Creación del Aula de Farmacovigilancia PVpharm – UGR

Creación del Aula de Farmacovigilancia PVpharm – UGR

  • Post published:October 26, 2023

El martes 24-10-2023 tuvo lugar en el Rectorado de la Universidad, la firma  Aula de Farmacovigilancia UGR & PVPharm, un espacio dedicado a incrementar el conocimiento y aprendizaje sobre Farmacovigilancia y la Industria Farmacéutica. Al acto de firma acudieron entre otros el Sr. Rector Magnífico de la Universidad, D. Pedro Mercado Pacheco, el CEO y fundador de PVPharm, D. José Alberto Ayala Ortiz, y el Sr. Decano de la Facultad,. D. Manuel Sánchez Polo. https://youtu.be/oJh6yrA3l5M El objetivo general de la presente colaboración entre PVpharm y la UGR es apoyar la realización de actividades de formación y difusión en el ámbito de la…

Continue ReadingCreación del Aula de Farmacovigilancia PVpharm – UGR
PVpharm participates in the 2023 European Researchers’ Night
Noche de los Investigadores 2023, PVpharm

PVpharm participates in the 2023 European Researchers’ Night

  • Post published:September 30, 2023

The European Researchers' Night is a Europe-wide public event, which displays the diversity of science and its impact on citizens' daily lives in fun, inspiring ways. This year, the event will take place in 26 countries on Friday 29 September 2022. The European Researchers' Night aims to: -bring research and researchers closer to the public-promote excellent research projects across Europe and beyond-increase the interest of young people in science and research careers-showcase the impact of researchers’ work on people’s daily lives The European Researchers’ Night attracts each year more than 1 million visitors in Europe and beyond. Researcher's Night 2023…

Continue ReadingPVpharm participates in the 2023 European Researchers’ Night
José Alberto Ayala Ortiz selected as one of the top ten CEOs of 2023

José Alberto Ayala Ortiz selected as one of the top ten CEOs of 2023

  • Post published:August 22, 2023

We are very glad to announce that José Alberto Ayala Ortiz has been selected as one of the top ten CEOs of 2023. Industry Tech Outlook has chosen José, a full article has been issued at the magazine website, it can be found here: https://industry-techoutlook.com/magazine/Top-10-CEOs-Of-2023/ Being the CEO of PVpharm, José is a visionary and inspirational leader. He sets a clear direction for the organization's future while motivating and uniting the organization. José’s leadership drives growth, innovation, and success, creating a positive work environment, attracting top talent, and building solid stakeholder relationships. The company has been growing in business since…

Continue ReadingJosé Alberto Ayala Ortiz selected as one of the top ten CEOs of 2023
Meet us in September! at Farmaforum (Madrid) and BIOSPAIN (Barcelona)

Meet us in September! at Farmaforum (Madrid) and BIOSPAIN (Barcelona)

  • Post published:August 18, 2023

PVpharm is going to participate in the next events of the pharmaceutical and biotechnology industry in Spain. Farmaforum will be held in Madrid from September 19 to 20, and BIOSPAIN will be held in Barcelona from September 26 to 28. Come visit us and let's talk about pharmacovigilance services, safety in clinical trials, audits, quality and many other topics related to drug development. We are looking forward to seeing you!

Continue ReadingMeet us in September! at Farmaforum (Madrid) and BIOSPAIN (Barcelona)
PVpharm starts a new collaboration with the International AIDS Vaccine Initiative (IAVI)

PVpharm starts a new collaboration with the International AIDS Vaccine Initiative (IAVI)

  • Post published:May 22, 2023

We are so excited to announce the new collaboration agreement signed by our company with the International AIDS Vaccine Initiative (IAVI) to provide pharmacovigilance and regulatory consulting. IAVI is a nonprofit scientific research organization that develops vaccines and antibodies for HIV, tuberculosis, emerging infectious diseases (including COVID-19), and other neglected diseases, with a clear commitment to develop affordable and accesible solutions to these diseases. In the same way as our collaboration with the Leiden University Medical Center (LUMC) or with the Center for Human Drug Research (CHDR), PVpharm works to provide pharmacovigilance support in pre-approval phases of the development of innovative drugs. In this agreement, we…

Continue ReadingPVpharm starts a new collaboration with the International AIDS Vaccine Initiative (IAVI)
We are in the press! El Economista

We are in the press! El Economista

  • Post published:May 9, 2023

PVpharm is in "El Economista" on 9th May 2023, the news diary published an article about PVpharm; where our CEO, José Alberto Ayala Ortiz, introduces our company, explains what pharmacovigilance is and how does PVpharm deal with different regulations. PVpharm is a global reference in Pharmacovigilance: https://www.eleconomista.es/branded-content/noticias/12258631/05/23/jose-alberto-ayala-ortiz-pvpharm-somos-una-referencia-global-en-el-campo-de-la-farmacovigilancia.html You can follow us on LinkedIn and learn more about us clicking here.

Continue ReadingWe are in the press! El Economista
PVpharm initiates a collaboration with the Leiden University Medical Center (LUMC) in the Netherlands

PVpharm initiates a collaboration with the Leiden University Medical Center (LUMC) in the Netherlands

  • Post published:May 3, 2023

We are happy to announce that PVpharm have enter in a new agreement with Leiden University Medical Center (LUMC) to provide safety and regulatory consulting. LUMC was formed from a collaboration between the Academic Hospital Leiden and the Faculty of Medicine of Leiden University, and provides scientific and material support to first steps of the drug development in humans. As an innovator, the LUMC stands for improving healthcare and people's health. This is done on the basis of leading research and innovative education. The objective of the LUMC is to be one of the top 10 University Medical Centers in…

Continue ReadingPVpharm initiates a collaboration with the Leiden University Medical Center (LUMC) in the Netherlands
PVpharm participates in “Feria de Empleo 2023” at the University of Almería
Feria de Empleo UAL 2023

PVpharm participates in “Feria de Empleo 2023” at the University of Almería

  • Post published:April 11, 2023

PVpharm will be participating in the “Feria de Empleo 2023”, along with other companies and organizations from Almería like Cosentino, Cajamar, Kimitec, FAAM or Verdiblanca. This job fair dedicates two days in which local companies have the opportunity to make themselves known in a closer way and thus create a common space where both, the student and the company, can mutually exchange and enrich each other. -When? Monday, 17th April: 10:30 am – 2 pm 4 pm – 7 pm Tuesday, 18th April: 10 am – 14 pm -Where? The main avenue of the University of Almeria

Continue ReadingPVpharm participates in “Feria de Empleo 2023” at the University of Almería
PVpharm to provide pharmacovigilance and CTIS support to the Centre for Human Drug Research of the Netherlands (CHDR).

PVpharm to provide pharmacovigilance and CTIS support to the Centre for Human Drug Research of the Netherlands (CHDR).

  • Post published:January 24, 2023

We are happy to announce that PVpharm have enter in a new agreement with Centre for Human Drug Research (CHDR) to provide safety and regulatory consulting. This prestigious foundation, based in Leiden (NL) and with three decades of history, provide scientific and material support to first steps of the drug development in humans (phase I and II of Clinical trials). Our collaboration will focus on helping about EMA’s Clinical Trial Information System (CTIS) and pharmacovigilance tasks, essential in these steps of drug development. With different therapeutic areas of research, CHDR is a leading organization in this field, with projects as…

Continue ReadingPVpharm to provide pharmacovigilance and CTIS support to the Centre for Human Drug Research of the Netherlands (CHDR).
Older Posts